Furthermore, patients with anti‐ACE2 IgM experienced more inflammatory arthritis, RP‐ILD, and worse FVC, all of which approached statistical significance (P ~ 0.05) despite the small number of patients. The gene discussed is ACE2; the disease is interstitial lung disease.